JEFFREY SCOTT: Open Payments
NPI 1821666496 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,485 in 90 payments from 13 companies in 2025. Trend: 2023 $2,103 · 2024 $1,878 · 2025 $1,485
Food & beverage: $1,484Education: $1
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $296 |
| ABBVIE INC. | 21 | $282 |
| Otsuka America Pharmaceutical, Inc. | 16 | $239 |
| Corium, LLC | 12 | $175 |
| Vanda Pharmaceuticals Inc. | 12 | $154 |
| Supernus Pharmaceuticals, Inc. | 6 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Lundbeck LLC | 2 | $39 |
| Vertical Pharmaceuticals, LLC | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
Products named: CAPLYTA, VRAYLAR, Azstarys, ABILIFY MAINTENA, FANAPT, Qelbree, REXULTI, TRINTELLIX.
Industry payments across AZ — which companies pay providers there.
